Our data suggest that the Keap1–Nrf2 pathway is activated in pancreatic cancer cell lines through UHRF1‐mediated suppression of Keap1 protein levels, with Keap1 promoter methylation potentially contributing to this. This evidence concerns the gene KEAP1 and pancreatic neoplasm.